Incyte (NASDAQ: INCY) moves closer to an hidradenitis suppurativa launch as 54-week povorcitinib data hold up
Takeda (NYSE: TAK) boosts psoriasis ambitions as Phase 3 zasocitinib data sharpen oral TYK2 challenge
‘No Kings’ protests sweep all 50 US states as millions march against Trump immigration crackdown and Iran war
Read More General business news Sayres Defense secures $280m NAVSEA contract for PMS 300/PMS 325 support services In a major development for defense contracting, Sayres Defense, a renowned provider of systems engineering and mission support… byPallavi MadhirajuFebruary 2, 2024